Cargando…
Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation
BACKGROUND: β-blockers (BBs) are considered primary therapy in stable heart failure (HF) with reduced ejection fraction (HFrEF) without atrial fibrillation (AF); evidence-based benefits of BB on outcome have been documented. However, BBs have not been shown to improve mortality or reduce hospital ad...
Autores principales: | Ahn, Min-Soo, Yoo, Byung-Su, Son, Jung-Woo, Yu, Min Heui, Kang, Dae Ryong, Lee, Hae-Young, Jeon, Eun-Seok, Kim, Jae-Joong, Chae, Shung Chull, Baek, Sang Hong, Kang, Seok-Min, Choi, Dong-Ju, Kim, Kye Hun, Cho, Myeong-Chan, Kim, Seong Yoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445305/ https://www.ncbi.nlm.nih.gov/pubmed/32830467 http://dx.doi.org/10.3346/jkms.2020.35.e278 |
Ejemplares similares
-
β‐Blockers and 1‐Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate
por: Park, Jin Joo, et al.
Publicado: (2019) -
Heart failure and atrial fibrillation: tachycardia‐mediated acute decompensation
por: Park, Jin Joo, et al.
Publicado: (2021) -
Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction: Results from The Korea Acute Heart Failure (KorAHF) Registry
por: Kim, Sung-Hwan, et al.
Publicado: (2018) -
Prognostic Impact and Predictors of New-Onset Atrial Fibrillation in Heart Failure
por: Choi, Hyo-In, et al.
Publicado: (2022) -
Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2020)